Pharmacology and pharmacogenetics of chemotherapeutic agents (Q37500096)

20 August 2017

1 reference

title

Pharmacology and pharmacogenetics of chemotherapeutic agents (English)

1 reference

20 August 2017

1 reference

1 reference

Shaheenah Dawood

1

1 reference

20 August 2017

Brian Leyland-Jones

series ordinal

2

1 reference

20 August 2017

language of work or name

1 reference

1 June 2009

1 reference

20 August 2017

1 reference

20 August 2017

volume

27

1 reference

20 August 2017

issue

5

1 reference

20 August 2017

page(s)

482-488

1 reference

Pharmacogenomics: translating functional genomics into rational therapeutics

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F07357900802574660

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802574660

A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802574660

Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802574660

Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802574660

The methylenetetrahydrofolate reductase C677T gene polymorphism decreases the risk of childhood acute lymphocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802574660

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802574660

Clinical pharmacokinetics of endocrine agents used in advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802574660

Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802574660

Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: prominent roles for CYP3A and CYP2D6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802574660

CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802574660

Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802574660

Fluorinated pyrimidines, a new class of tumour-inhibitory compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802574660

5-Fluorouracil: forty-plus and still ticking. A review of its preclinical and clinical development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802574660

Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802574660

Drug-Related Morbidity and Mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802574660

10.1080/07357900802574660

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference